title: High-efficiency retroviral transduction of mammalian cells on positively charged surfaces.
abstract: The efficiency of retroviruses as transducing agents has been appreciated for many years, particularly for hematopoietic cell targets for which alternative strategies applicable to adherent cells are not effective. Advances in vector design, pseudotyping, and infection conditions have eliminated the need to cocultivate the target cells with virus-producing cells. Nevertheless, improvements are still needed for many applications, including those with a therapeutic or clinical cell-tracking objective. In this study we show that more positively charged surfaces, including those designed for the culture of anchorage-dependent cells, allow measurable levels of adhesion by different pseudotypes of retroviruses, which can result in increased gene transfer efficiencies to a variety of target cells including normal primary human hematopoietic cells as well as human leukemic cell lines and rat and murine fibroblasts. In the experiments with primary human cells, equal aliquots of enriched CD34+ cord blood cells were first stimulated for 2 days with cytokines (Flt3 ligand, Steel factor, IL-3, IL-6, and G-CSF) and then exposed for 4 days to a green fluorescent protein (GFP)- and Neo(r)-encoding retrovirus produced in PG13 cells. Both the final yield (approximately 300% relative to initial numbers), and the proportion (approximately 60%) of transduced CD34+ cells, colony-forming cells, and long-term culture-initiating cells were the same for cells infected either in tissue culture dishes or in fibronectin-coated petri dishes. Similar proportions (approximately 10%) and absolute yields of GFP+ human cells were also found in multilineage engrafted NOD/SCID mice assessed 6 to 8 weeks after being transplanted with these two types of transduced, but unselected, cells. These findings suggest a new and simpler approach for achieving high gene transfer efficiencies to hematopoietic cells.
authors.affiliation: British Columbia Cancer Agency and Department of Medicine, University of British Columbia, Vancouver, Canada.
authors.forename: B
authors.initials: B
authors.lastname: Hennemann
authors.forename: J Y
authors.initials: JY
authors.lastname: Chuo
authors.forename: P D
authors.initials: PD
authors.lastname: Schley
authors.forename: K
authors.initials: K
authors.lastname: Lambie
authors.forename: R K
authors.initials: RK
authors.lastname: Humphries
authors.forename: C J
authors.initials: CJ
authors.lastname: Eaves
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D018014:Gene Transfer Techniques; D006801:Humans; D051379:Mice; D051381:Rats; D012190:Retroviridae / Q000235:genetics*; D014161:Transduction, Genetic; D014407:Tumor Cells, Cultured